Table A.2.
OLS Regression Model Predicting Number of Naloxone Doses, N = 7,435
| Outcome: Number of Naloxone Doses | B | 95% CI1 | p-value |
|---|---|---|---|
|
| |||
| Race | |||
| White | — | — | |
| Black | −0.02 | −0.06, 0.02 | 0.402 |
| Other2 | 0.18 | −0.03, 0.40 | 0.100 |
| Age | |||
| 25–44 | — | — | |
| 45–64 | 0.08 | 0.03, 0.12 | <0.001 |
| 65+ | −0.24 | −0.42, −0.06 | 0.008 |
| 18–24 | −0.03 | −0.07, 0.01 | 0.191 |
| Under 18 | 0.11 | −0.07, 0.28 | 0.236 |
| Sex | |||
| Male | — | — | |
| Female | −0.04 | −0.08, −0.01 | 0.011 |
| Drugs Involved | |||
| Opioids Alone | — | — | |
| Opioids & Non-Stimulants | 0.09 | 0.03, 0.15 | 0.002 |
| Stimulant & Opioids Combined | 0.02 | −0.05, 0.10 | 0.519 |
| Other Drug(s)3 | −0.09 | −0.20, 0.02 | 0.117 |
| Fentanyl | |||
| Not Suspected | — | — | |
| Suspected | 0.14 | 0.10, 0.17 | <0.001 |
| Naloxone Type | |||
| Nasal Naloxone | — | — | |
| Intramuscular Naloxone | 0.05 | 0.01, 0.10 | 0.020 |
| Intravenous Naloxone | −0.12 | −0.21, −0.03 | 0.009 |
| Multiple Types of Naloxone | 0.91 | 0.86, 0.96 | <0.001 |
| ODFR Respondent | |||
| Stranger | — | — | |
| Self | −0.08 | −0.14, −0.02 | 0.007 |
| Friend | 0.06 | −0.01, 0.13 | 0.104 |
| Family | 0.04 | −0.02, 0.10 | 0.220 |
| Other4 | −0.12 | −0.29, 0.05 | 0.152 |
| Emergency Responder | −0.26 | −0.30, −0.22 | <0.001 |
| Behavioral Health Professional | −0.04 | −0.14, 0.05 | 0.384 |
| Year | −0.03 | −0.04, −0.01 | <0.001 |
1
CI = Confidence Interval
2
Includes Asian, Native American, and multiracial individuals.
3
Includes alcohol, stimulants alone, benzodiazepines, and responses of “other” without additional detail.
4
Includes neighbors and responses of “other” without additional detail.